Peter Svalander

1.0k total citations
25 papers, 786 citations indexed

About

Peter Svalander is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Peter Svalander has authored 25 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Reproductive Medicine, 14 papers in Public Health, Environmental and Occupational Health and 7 papers in Molecular Biology. Recurrent topics in Peter Svalander's work include Reproductive Biology and Fertility (14 papers), Ovarian function and disorders (7 papers) and Sperm and Testicular Function (6 papers). Peter Svalander is often cited by papers focused on Reproductive Biology and Fertility (14 papers), Ovarian function and disorders (7 papers) and Sperm and Testicular Function (6 papers). Peter Svalander collaborates with scholars based in Sweden, United Kingdom and Denmark. Peter Svalander's co-authors include M. Bygdeman, Matts Wikland, Kristina Gemzell‐Danielsson, B. Ove Nilsson, M.L. Swahn, Anders Larsson, Lars Hamberger, Å. Bengtsson, Per Odin and Elisabeth Johannisson and has published in prestigious journals such as Development, The Journal of Clinical Endocrinology & Metabolism and Human Reproduction.

In The Last Decade

Peter Svalander

25 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Svalander Sweden 16 506 427 260 144 129 25 786
Alan B. Dudkiewicz United States 16 363 0.7× 271 0.6× 245 0.9× 75 0.5× 67 0.5× 34 814
Marie-Claude Léveillé Canada 16 466 0.9× 568 1.3× 168 0.6× 253 1.8× 192 1.5× 28 900
Shinji Komori Japan 15 204 0.4× 118 0.3× 136 0.5× 209 1.5× 55 0.4× 54 581
Carole C. Wegner United States 10 292 0.6× 200 0.5× 246 0.9× 119 0.8× 25 0.2× 14 533
Indira Hinduja India 20 639 1.3× 552 1.3× 214 0.8× 378 2.6× 106 0.8× 52 1.1k
Masatsune Fukuoka Japan 13 230 0.5× 210 0.5× 309 1.2× 53 0.4× 75 0.6× 21 670
Harry M. Weitlauf United States 18 167 0.3× 566 1.3× 466 1.8× 457 3.2× 74 0.6× 50 1.1k
E. Johannisson Sweden 20 695 1.4× 541 1.3× 527 2.0× 90 0.6× 91 0.7× 60 1.2k
Themis Mantzavinos Greece 15 544 1.1× 462 1.1× 169 0.7× 89 0.6× 159 1.2× 41 765
W. Ian H. Johnston Australia 24 1.6k 3.2× 1.5k 3.5× 105 0.4× 276 1.9× 327 2.5× 42 1.9k

Countries citing papers authored by Peter Svalander

Since Specialization
Citations

This map shows the geographic impact of Peter Svalander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Svalander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Svalander more than expected).

Fields of papers citing papers by Peter Svalander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Svalander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Svalander. The network helps show where Peter Svalander may publish in the future.

Co-authorship network of co-authors of Peter Svalander

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Svalander. A scholar is included among the top collaborators of Peter Svalander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Svalander. Peter Svalander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macklon, Nick, et al.. (2021). Embryos are exposed to a significant drop in temperature during the embryo transfer procedure: a pilot study. Reproductive BioMedicine Online. 43(2). 193–195. 3 indexed citations
2.
3.
Hambiliki, Fredwell, et al.. (2008). Vitrification with DMSO protects embryo membrane integrity better than solutions without DMSO. Reproductive BioMedicine Online. 17(3). 378–384. 28 indexed citations
4.
Blake, Deborah, Peter Svalander, Meishan Jin, Christer Silversand, & L. Kevin Hamberger. (2002). Protein Supplementation of Human IVF Culture Media. Journal of Assisted Reproduction and Genetics. 19(3). 137–143. 35 indexed citations
5.
Holmes, Paul, R Racho El-Akouri, & Peter Svalander. (1997). The Antibody-neutralisation of PDGF, CSF-1, TGFb2,3, EGF and EGF-receptorin uteroin Pre-implantation Mice. Upsala Journal of Medical Sciences. 102(1). 41–48. 3 indexed citations
6.
Svalander, Peter, et al.. (1996). The outcome of intracytoplasmic sperm injection is unrelated to 'strict criteria' sperm morphology. Human Reproduction. 11(5). 1019–1022. 81 indexed citations
7.
Svalander, Peter, et al.. (1995). Factors of importance for the establishment of a successful program of intracytoplasmic sperm injection treatment for male infertility. Fertility and Sterility. 63(4). 828–837. 62 indexed citations
8.
Hamberger, Lars, A. Sjögren, Kersti Lundin, et al.. (1995). Microfertilization techniques--the Swedish experience. Reproduction Fertility and Development. 7(2). 263–267. 24 indexed citations
9.
10.
Svalander, Peter, Matts Olovsson, & Paul Holmes. (1994). Mycotoxin effects on in vitro preimplantation embryo development. Journal of Assisted Reproduction and Genetics. 11(3). 172–175. 2 indexed citations
11.
Wikland, Matts, et al.. (1994). Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Human Reproduction. 9(8). 1430–1436. 68 indexed citations
12.
Gemzell‐Danielsson, Kristina, et al.. (1994). Implantation: Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase. Human Reproduction. 9(12). 2398–2404. 69 indexed citations
13.
Svalander, Peter, et al.. (1994). Subzonal insemination (SUZI) or in vitro fertilization (IVF) in microdroplets for the treatment of male-factor infertility. Journal of Assisted Reproduction and Genetics. 11(3). 149–155. 4 indexed citations
14.
Gemzell‐Danielsson, Kristina, M.L. Swahn, Peter Svalander, & M. Bygdeman. (1993). Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Human Reproduction. 8(6). 870–873. 116 indexed citations
15.
Bygdeman, M., M.L. Swahn, Kristina Gemzell‐Danielsson, & Peter Svalander. (1993). Mode of Action of RU 486. Annals of Medicine. 25(1). 61–64. 23 indexed citations
16.
Svalander, Peter, Paul Holmes, Matts Olovsson, et al.. (1991). Platelet-derived growth factor is detected in human blastocyst culture medium but not in human follicular fluid—a preliminary report. Fertility and Sterility. 56(2). 367–369. 22 indexed citations
17.
Svalander, Peter, Per Odin, Bengt‐Olof Nilsson, & Björn Öbrink. (1990). Expression of cellCAM-105 in the apical surface of rat uterine epithelium is controlled by ovarian steroid hormones. Reproduction. 88(1). 213–221. 26 indexed citations
18.
Svalander, Peter, et al.. (1989). Mouse blastocyst surface expression of galactose-containing epitopes coinciding with trophoblast differentiation. Cell Differentiation and Development. 26(3). 191–200. 6 indexed citations
19.
Svalander, Peter, et al.. (1987). Intrasplenic immunization for production of monoclonal antibodies against mouse blastocysts. Journal of Immunological Methods. 105(2). 221–227. 20 indexed citations
20.
Nilsson, B. Ove, et al.. (1986). Methods for Production and Detection of Monoclonal Antibodies against Surface Components of Adhesive Implanting Mouse Blastocysts. Upsala Journal of Medical Sciences. 91(3). 317–322. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan B. Dudkiewicz Breakdown of academic impact, for papers by Marie-Claude Léveillé Breakdown of academic impact, for papers by Shinji Komori Breakdown of academic impact, for papers by Carole C. Wegner Breakdown of academic impact, for papers by Indira Hinduja Breakdown of academic impact, for papers by Masatsune Fukuoka Breakdown of academic impact, for papers by Harry M. Weitlauf Breakdown of academic impact, for papers by E. Johannisson Breakdown of academic impact, for papers by Themis Mantzavinos Breakdown of academic impact, for papers by W. Ian H. Johnston
Rankless by CCL
2026